MedImmune Plans To Expand Sales Force As It Reacquires Synagis Promotion Rights
This article was originally published in The Pink Sheet Daily
Executive Summary
Abbott will release co-promotion rights for the respiratory syncytial virus therapy effective June 30, 2006.